Version history

{
  "session_id": "sess_SDA-2026-04-12-gap-debate-20260410-113038-57244485_20260412-215703",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"Cx43 CTD-β-Catenin Sequestration Controls TNT Biogenesis\",\n      \"mechanism\": \"Cx43 C-terminal domain binding to β-catenin (residues 242-283) prevents its nuclear translocation, reducing actin remodeling necessary for tunneling nanotube formation.\",\n      \"target_gene\": \"GJA1\",\n      \"confidence_score\": 0.7,\n      \"novelty_score\": 0.6,\n      \"feasibility_score\": 0.5,\n      \"impact_score\": 0.8,\n      \"composite_score\": 0.695,\n      \"testable_prediction\": \"Cx43-ΔCTD mutant overexpression will increase TNT density and mitochondrial transfer despite normal gap junction function.\",\n      \"skeptic_concern\": \"Multi-step causal chain has many breakpoints; β-catenin necessity does not prove Cx43 sequestration is the controlling mechanism.\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"Cx43 Expression Level Determines Gap Junction vs. TNT Dominance\",\n      \"mechanism\": \"High Cx43 expression sequesters β-catenin at gap junction plaques, suppressing TNT biogenesis and favoring direct cell-cell transfer; low Cx43 allows β-catenin nuclear activity promoting TNT-dependent mitochondrial transport.\",\n      \"target_gene\": \"GJA1\",\n      \"confidence_score\": 0.6,\n      \"novelty_score\": 0.55,\n      \"feasibility_score\": 0.55,\n      \"impact_score\": 0.75,\n      \"composite_score\": 0.63,\n      \"testable_prediction\": \"Gradual Cx43 knockdown (siRNA titration) will show dose-dependent switch from gap junction-mediated to TNT-mediated mitochondrial transfer.\",\n      \"skeptic_concern\": \"Dose-response relationship has not been quantified, and compensatory pathways may confound interpretation of expression-level manipulation.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"Hemichannel-Dependent Mitochondrial Release Bypasses Gap Junctions\",\n      \"mechanism\": \"Cx43 hemichannels (non-junctional) mediate mitochondrial particle release from donor cells independently of gap junction formation, with transfer completed via TNTs to recipient cells.\",\n      \"target_gene\": \"GJA1\",\n      \"confidence_score\": 0.5,\n      \"novelty_score\": 0.65,\n      \"feasibility_score\": 0.45,\n      \"impact_score\": 0.7,\n      \"composite_score\": 0.585,\n      \"testable_prediction\": \"Non-junctional hemichannel blockade (carbenoxolone) will reduce mitochondrial release from donors while gap junction-intact recipients still receive particles via TNTs.\",\n      \"skeptic_concern\": \"Distinguishing hemichannel-dependent from gap junction-dependent mechanisms requires technically challenging spatial control of drug application.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"Cx43 is involved in mitochondrial transfer between cells\",\n    \"The C-terminal domain binds β-catenin at defined residues (242-283)\",\n    \"Therapeutic targeting of Cx43 pathways requires mechanistic disambiguation\"\n  ],\n  \"dissent_points\": [\n    \"Whether Cx43-mediated transfer uses gap junctions, TNTs, or both pathways remains contested\",\n    \"The Expert favors translational-applicable hypotheses over theoretically complete mechanisms, unlike the Theorist\"\n  ],\n  \"debate_summary\": \"The debate reveals that while Cx43's role in mitochondrial transfer is established, whether it operates through gap junctions, TNTs, or hybrid mechanisms remains unresolved. The Skeptic's mechanistic critique highlights that the CTD-β-catenin hypothesis involves a causal chain with multiple vulnerable breakpoints, and the Expert emphasizes that therapeutic development requires prioritizing testable pathways over comprehensive mechanistic models.\"\n}",
  "tokens_used": "886"
}